Vimarsana
Biggest News Aggregation in the World

Flurotest Diagnostics Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Flurotest Diagnostics Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Flurotest Diagnostics Systems Today - Breaking & Trending Today

FluroTech Provides Operational Update: Announces Pause on - Vimarsana News

FluroTech Provides Operational Update: Announces Pause on

CALGARY, Alberta, April 08, 2022 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (the “Company” or “FluroTech”), announces that it has...

FluroTech Provides Operational Update: Announces Pause on Further Development of its Pandemic and Emerging Disease Defense Platform - Vimarsana News

FluroTech Provides Operational Update: Announces Pause on Further Development of its Pandemic and Emerging Disease Defense Platform

09.04.2022 - CALGARY, Alberta, April 08, 2022 (GLOBE NEWSWIRE) - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (the “Company” or “FluroTech”), announces that it has decided to pause any further expenditures on development of its Pandemic and Emerging Disease ...

Former US Assistant Health Secretary Dr. Joxel Garcia Joins FluroTest as Chief Medical Officer and Executive Team Member - Vimarsana News

Former US Assistant Health Secretary Dr. Joxel Garcia Joins FluroTest as Chief Medical Officer and Executive Team Member

/PRNewswire/ - FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...

FluroTest and SNC-Lavalin Sign MoU to Bring Saliva Sample-Based SARS-CoV-2 Testing Solution System to Market in Canada and Beyond - Vimarsana News

FluroTest and SNC-Lavalin Sign MoU to Bring Saliva Sample-Based SARS-CoV-2 Testing Solution System to Market in Canada and Beyond

/PRNewswire/ - FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostics Systems ("FluroTest" or The Company), a diagnostics...

FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System - Vimarsana News

FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System

CALGARY, AB, May 10, 2021 /PRNewswire/ -  FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary "FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces the next phase of its ongoing clinical trials with its trial partner Toolbox Medical Innovations ("Toolbox"). The Company is pleased to report that approximately 600 volunteer participants, including both symptomatic and asymptomatic individuals, are being identified from six clinical site locations across Califor...